About Flash Therapy
Flash radiotherapy is a novel external non-invasive radiotherapy technique that consists of delivering a high dose of radiation at an ultra-high dose rate. When compared to radiotherapy delivered at conventional dose rates (1 – 7 cGy/sec), the Flash phenomenon seems to appear when irradiation is delivered with a dose superior to 8 Gy and at a dose rate above 33 Gy/sec in a very short time (less than a second). In other words, healthy tissue seems to withstand this novel method of irradiation better, while the tumor has the same level of sensitivity to Flash irradiation as to conventional treatment.
About IBA
IBA (Ion Beam Applications S.A.) is a global medical technology company focused on bringing integrated and innovative solutions for the diagnosis and treatment of cancer. The company is the worldwide technology leader in the field of proton therapy, considered to be the most advanced form of radiation therapy available today. IBA's proton therapy solutions are flexible and adaptable, allowing customers to choose from universal full-scale proton therapy centers as well as compact, single room solutions. In addition, IBA has a radiation dosimetry business and develops particle accelerators for the medical world and industry. Headquartered in Belgium and employing about 1,400 people worldwide, IBA has the largest number of installed proton therapy systems across the world.
About the Rutherford Cancer Centres
The Rutherford Cancer Centres are at the forefront of providing advanced cancer care and creating a better future for cancer patients. The centres provide an all-encompassing cancer service, delivering world-class imaging, chemotherapy, immunotherapy, radiotherapy and proton beam therapy treatment.
Back to HCB News
